• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

{bigtriangleup}9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen Presenting Cells and the Cannabinoid R

tetano

Editor, Senior Moderator
Toxicol Sci. 2012 Nov 14. [Epub ahead of print]
{bigtriangleup}9-Tetrahydrocannabinol Impairs the Inflammatory Response to Influenza Infection: Role of Antigen Presenting Cells and the Cannabinoid Receptors 1 and 2.
Karmaus PW, Chen W, Crawford R, Kaplan BL, Kaminski NE.
Source

Cell and Molecular Biology Program, Michigan State University, East Lansing, MI, 48824, USA.
Abstract

△(9)-tetrahydrocannabinol (△(9)-THC) has potent immune modulatory properties and can impair pathogen-induced immune defenses, which in part have been attributed to ligation of the cannabinoid receptors 1 (CB(1)) and 2 (CB(2)). Most recently, dendritic cells (DC) were identified for their potential to enhance influenza-induced immunopathology in mice lacking CB(1) and CB(2) (CB(1)(-/-)CB(2)(-/-)). The present study focused on the modulation of the inflammatory immune response to influenza by △(9)-THC and the role of CB(1) and/or CB(2) as receptor targets for △(9)-THC. C57Bl/6 (WT) and CB(1)(-/-)CB(2)(-/-) mice were administered △(9)-THC (75 mg/kg) surrounding the intranasal instillation of A/PR/8/34 influenza virus. Three days post infection (dpi), △(9)-THC broadly decreased expression levels of mRNA induced by the innate immune response to influenza, suppressed the percentage of IFN-γ-producing CD4(+) and IL-17-producing NK1.1(+)cells, and reduced the influx of antigen presenting cells (APC), including inflammatory myeloid cells and monocytes/macrophages into the lung in a CB(1)- and/or CB(2)-dependent manner. △(9)-THC had little effect on the expression of CD86, MHC I, and MHC II by APC isolated from the lung. In vitro studies demonstrated that lipopolysaccharide (LPS)-induced maturation was suppressed by △(9)-THC in bone marrow-derived DC (bmDC). Furthermore, antigen-specific IFNγ production by CD8(+) T cells after co-culture was reduced by △(9)-THC-treatment of bmDC in a CB(1)- and/or CB(2)-dependent manner. Collectively, these studies suggest that △(9)-THC potently suppresses myeloid cell immune function, in a manner involving CB(1)- and/or CB(2), thereby impairing immune responses to influenza infection.

PMID:
23152191
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23152191
 
Back
Top Bottom